313 related articles for article (PubMed ID: 1906791)
41. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
Jernstrom H; Knutsson M; Olsson H
Contraception; 1995 Jul; 52(1):51-6. PubMed ID: 8521715
[TBL] [Abstract][Full Text] [Related]
42. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
Nuttall ID; Elstein M; Fahmy DR
Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424
[TBL] [Abstract][Full Text] [Related]
43. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
Ryu K; Yu HK; Kwak HM; Hong SS
Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
Back DJ; Breckenridge AM; Grimmer SF; Orme ML; Purba HS
Contraception; 1984 Sep; 30(3):289-95. PubMed ID: 6439467
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
Kuhnz W; Staks T; Jütting G
Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
[TBL] [Abstract][Full Text] [Related]
46. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
47. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
49. Lansoprazole does not affect the bioavailability of oral contraceptives.
Fuchs W; Sennewald R; Klotz U
Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
[TBL] [Abstract][Full Text] [Related]
50. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Jung-Hoffmann C; Fitzner M; Kuhl H
Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
[TBL] [Abstract][Full Text] [Related]
51. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
Alvarez F; Faundes A; Johansson E; Coutinho E
Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
[TBL] [Abstract][Full Text] [Related]
52. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
53. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
54. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
55. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
56. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
Fraser IS; Jansen RP
Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
[TBL] [Abstract][Full Text] [Related]
57. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
van der Spuy ZM; Sohnius U; Pienaar CA; Schall R
Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047
[TBL] [Abstract][Full Text] [Related]
58. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
[TBL] [Abstract][Full Text] [Related]
59. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
el-Raghy I; Back DJ; Makeram M; Salem H; Osman F; Fathalla M; Orme ML
Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]